Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Lifelong Montrealer Susan Kahn has dedicated her career to helping people who experience thrombosis, from those diagnosed with cancers to young women that are...

Lebanon is a small country in the Eastern Mediterranean. There are 4 million Lebanese residing in the country, and according to the WHO Annual...

The results of this study suggest that GPRC5D is an active target for immunotherapy in multiple myeloma. GPRC5D-targeted CAR T-cell therapy is a promising...

2022 ASH annual meeting - 4 days

Mashup Score:3

Johannes Schetelig (University Hospital Technical University Dresden, Dresden, Germany) presented results from the phase 3 ASAP trial (NCT02461537), which tested whether intensive chemotherapy before...

Our results suggest that a sex-informed approach can improve the personalised decision making process in patients with myelodysplastic syndromes and should be considered in...

Sex has long been relevant in patients with myelodysplastic syndromes given there is a higher prevalence1 and poorer prognosis2 among men compared with women....

KCd did not meet the criteria for non-inferiority compared with autologous HSCT, but the marginal difference in progression-free survival suggests that further studies are...

KCd did not meet the criteria for non-inferiority compared with autologous HSCT, but the marginal difference in progression-free survival suggests that further studies are...

High-dose melphalan followed by autologous haematopoietic stem-cell transplantation (HSCT) has been the standard-of-care in multiple myeloma treatment for the past 30 years. However, with...